American biotechnology company Gilead Sciences, facing mounting criticism over the high price of its new hepatitis C pill Sovaldi, has offered to supply the medicine to Egypt at a 99 per cent discount to the US price.
While the dr
Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration.
India supplies about 40 percent of gener
New details of a notorious drug smuggling gang that was operating in Bahrain have come to light.
Twenty-three men were apprehended last November when an estimated BD2 million ($5.2 million) worth of raw heroin was discovered at an
The drug addiction test being carried out by the Saudi Health Ministry for prospective brides and grooms has been termed as useless by a senior official.
The tests have failed to measure addiction levels and thus determine marriag
More than 11 tonnes of different drugs were seized last year by UAE’s Ministry of Interior.
Colonel Saeed Al Suwaidi, Director General of the Anti-Narcotics Federal Directorate General at the Ministry of Interior, revealed t
Pharmacy owners in Bahrain have decided to continue to sell medicines at old prices until they reach an agreement with the National Health Regulatory Authority, said a report.
At a press Conference attended by about 50 pharmacy ow
Bahrain is suffering an 'epidemic' of young people using illegal performance enhancing drugs, according to fitness experts.
Health officials have confiscated hundreds of shipments of steroids, body enhancing substances and
US health regulators expanded the approval of Roche Holding's breast cancer drug Perjeta and will now allow its use to help shrink tumors prior to surgery, the Food and Drug Administration said on Monday.
The decision followed
US health regulators have strengthened the warnings on two blood cancer drugs to reflect the risk that they may reactivate the hepatitis B virus in patients previously infected with the disease.
The warnings affect GlaxoSmithKline
The hunt for new heart drugs is losing momentum as resources are switched to other areas, notably cancer research, where investors get a better bang for their buck.
Cardiologists fear the fight against heart di